Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
ASG-5ME is an antibody-drug conjugate comprising an anti-SLC44A4 antibody linked to MMAE, which delivers the cytotoxic agent to SLC44A4-expressing tumor cells, potentially resulting in increased tumor cell death and decreased tumor growth (PMID: 27550944, PMID: 30725389).
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|ASG-5ME + Nab-paclitaxel||ASG-5ME Nab-paclitaxel||0||0|